1 documents found
Information × Registration Number 0120U102879, R & D request Title Additional multicenter, open-label, phase 3 study to evaluate oral ozanimod in patients with moderate to severe active Crohn's disease Head Skrypnyk Ihor M., Доктор медичних наук Registration Date 16-06-2020 Organization Ukrainian medical stomatological Academy popup.description1 Phase 3 study to evaluate oral ozanimod in patients with moderate or severe Crohn's disease in active form popup.nrat_date 2024-12-10 Close
search.res_rk
Additional multicenter, open-label, phase 3 study to evaluate oral ozanimod in patients with moderate to severe active Crohn's disease
Head: Skrypnyk Ihor M.. Additional multicenter, open-label, phase 3 study to evaluate oral ozanimod in patients with moderate to severe active Crohn's disease. Ukrainian medical stomatological Academy. № 0120U102879
1 documents found

Updated: 2026-03-27


Роздрукувати цю сторінку